A global Regulatory client based in the USA approached Freyr to assist them with filing original IND and amendment submissions to the US FDA. Freyr was challenged to work on significant volumes of documents, such as Module 4 and 5 documents, in a defined time. Freyr supported the client with end-to-end publishing activities and delivered the submission within very stringent timelines.

Download the proven case to learn how Freyr provided the client with valid submissions without any errors and warnings while completing submissions on time.

Download